Prophylaxis for Venous Thromboembolic Events in Elective Total Hip and Total Knee Arthroplasty.


Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
2022
Historique:
received: 01 10 2021
accepted: 09 03 2022
pubmed: 21 4 2022
medline: 18 6 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Venous thromboembolism (VTE) is a serious complication after major orthopaedic operations, such as a total hip (THA) and knee (TKA) arthroplasty. Therefore, perioperative VTE prophylaxis is recommended; a multitude of modern options are available, including both pharmacologic (aspirin, unfractionated and lowmolecular- weight heparin, vitamin K antagonists, and novel oral anticoagulants) and/or mechanical interventions (early mobilization, graduated compression stockings, intermittent pneumatic compression devices, and venous foot pumps). However, because of the abundance of these possibilities, it is crucial to understand the benefits and drawbacks of each VTE prophylaxis option to ensure that the optimal treatment plan is developed for each patient. The American College of Chest Physicians (AACP) and the American Academy of Orthopaedic Surgeons (AAOS) have both published individual guidelines on VTE prophylaxis regimens, alongside numerous studies evaluating the efficacy and outcomes of the different prophylaxis modalities. The purpose of this review is to provide a summary of the evidence on VTE prophylaxis after elective total hip and knee arthroplasty based on current guidelines and highlight the major concerns and potential complications.

Identifiants

pubmed: 35440299
pii: CPD-EPUB-122636
doi: 10.2174/1381612828666220418090928
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

771-777

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Theofilos Karasavvidis (T)

School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Vasileios Bouris (V)

Department of Vascular Surgery, General Hospital of Athens G. Genimatas, Athens, Greece.

William Xiang (W)

Department of Orthopaedic Surgery, University of Ioannina, School of Medicine, Ioannina, Greece.

Georgios Tzavellas (G)

Department of Vascular Surgery, Ball Memorial Hospital, Muncie, IN, USA.

Nektarios Charisis (N)

Department of Surgery, Stony Brook University Hospital, Stony Brook, NY, USA.

Leonidas Palaiodimos (L)

Department of Medicine, Albert Einstein College of Medicine, The Bronx, NY, USA.

Vassiliki Kigka (V)

School of Medicine, University of Ioannina, Ioannina, Greece.

Christos V Bourantas (CV)

Institute of Cardiovascular Sciences, University College London, London, UK.
Department of Cardiology, Barts Health NHS Trust, London, UK.

Ioannis Gkiatas (I)

Department of Orthopaedic Surgery, University of Ioannina, School of Medicine, Ioannina, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH